Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Life Technologies was a U.S.-based life sciences company formed in 2008 through the merger of Invitrogen and Applied Biosystems. The company sold research tools, instruments, reagents, consumables, and diagnostics-related products spanning genomics, proteomics, cell biology, molecular biology, and applied testing markets. Its portfolio included widely used brands such as Applied Biosystems, Invitrogen, Ion Torrent, GIBCO, Ambion, Molecular Probes, Novex, and TaqMan. Life Technologies was acquired by Thermo Fisher Scientific in February 2014, and its businesses were largely integrated into Thermo Fisher's Life Sciences Solutions segment. It was not a therapeutics developer in the usual biotech sense, but rather a commercial life science tools and enabling technologies company serving research, clinical, and industrial customers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LifeTech.